Markets
News
Analysis
Tools
Learn
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-cai
/
Caris Life Sciences Inc
CAI
29.500
USD
+1.980
+7.19%
Close 07/30, 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 07/31, 09:30 (ET)
8.20B
Market Cap
Loss
P/E TTM
Caris Life Sciences Inc
29.500
+1.980
+7.19%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
Total revenue
--
120.92M
Revenue
--
120.92M
Cost of revenue
--
63.85M
Operating expenses
--
178.87M
R&D expenses
--
23.07M
Depreciation, depletion, and amortization
--
7.04M
Other operating expenses
--
1.00K
Operating profit
--
-57.95M
Net non-operating interest income (expenses)
Non-operating interest income
--
503.00K
Non-operating interest expense
--
12.78M
Special income (expenses)
--
-32.33M
Other non-operating income (expenses)
--
-17.00K
Income before tax
--
-102.58M
Income tax
--
0.00
Income after tax
--
-102.58M
Net income from continuous operations
--
-102.58M
Net income attributable to controlling interests
--
-127.04M
Preferred share dividend
--
24.46M
Net income attributable to common shareholders
--
-127.04M
Basic earnings per share
--
-0.46
Diluted earnings per share
--
-0.46
Dividend per share
--
0.00
Currency unit
USD
Audit opinions
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up